Menopausal hormone replacement therapy has been touted as a longevity drug for women and a danger to their health. Is the government’s call to remove the black-box warning a good idea?

Menopausal hormone replacement therapy (HRT) has been both praised as a potential longevity drug for women and criticized as a health risk. The ongoing debate centers around the government's recent proposal to remove the black-box warning associated with this therapy, which has raised concerns among health professionals and patients alike. This warning has historically indicated serious risks, leading to a cautious approach to HRT usage. The implications of this proposal could significantly impact women's health management and treatment options.